Medical Devices Startups

Ourry Medical is a healthcare company focused on integrating and improving expertise centered on patient outcomes, combining technology and human expertise to deliver comprehensive solutions for healthcare needs.

1 investor

Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers. The company manufactures in North America and operates across the United States.

1 investor

Overture develops precision antibody therapeutics for obesity treatment, targeting metabolic dysfunction pathways to reduce fat mass while preserving lean muscle through monthly-dosed therapeutic approaches.

1 investor

Ownmed Innovation is a spin-off that develops medical devices and technologies to address unmet clinical needs, taking products through preclinical studies, clinical trials, and CE certification under EU regulation 2017/745. Its focus includes ostomy care, with a device aimed at restoring continence.

1 investor

Oxford Medical Products develops medical devices, drawing on a team of biotech entrepreneurs, material scientists, polymer chemists and medical device engineers.

1 investor

OXOS develops portable digital radiography devices for orthopedic surgery, enabling point-of-care diagnostic imaging in medical facilities and surgical settings nationwide. The company manufactures the MC2, an advanced iteration of its original Micro C device designed to expand access to radiographic diagnostics.

1 investor

Oxurion is a French specialist in clinical biometrics and data management, providing the core technology for the Oxurion platform.

1 investor

OxVent designs and produces a low-cost electro-mechanical medical ventilator, originally developed for the UK Government's 2020 Ventilator Challenge by engineers and medics from the University of Oxford and King's College London. Operating as a social venture, the company deploys its ventilator for use during and beyond the COVID-19 pandemic.

1 investor

OxyPrem develops non-invasive sensors that provide real-time monitoring of oxygen levels in human tissue, aimed at neonatal intensive care and the treatment of premature and other vulnerable patients. Its technology targets clinical teams, with an early focus on the Swiss NICU market.

1 investor

oyora operates a network of medical facilities offering interdisciplinary diagnostics and treatment, with a focus on radiology using cross-sectional imaging equipment. It coordinates specialists across locations to provide patient care in Germany, open to patients regardless of insurance type.

1 investor

P95 is a clinical research and pharmaceutical services company that supports pharmaceutical development through medical monitoring, epidemiology, biostatistics, study management, pharmacovigilance, and medical writing services.

1 investor

P-Mind develops non-invasive therapeutic technologies based on decades of research into magnetic fields and their interaction with living organisms, with a focus on treating pain disorders, neurological diseases, and cancer. The company manufactures and sells medical devices, including the alternating magnetic field therapy device "Eight" (エイト).

1 investor

Pacific Biosciences manufactures consumables and reagent kits for long-read DNA and RNA sequencing platforms, serving genomics research and diagnostics labs.

1 investor

Pacify Medical develops biomedical devices for wound management, specifically surgical and trauma wound care. The company's flagship product is a patent-protected skin spray device designed to improve wound healing outcomes.

1 investor

PACIV provides industrial automation controls, instrumentation, and system validation services for biotechnology, pharmaceutical, medical device, food & beverage, and utilities sectors. The company operates across the United States, Puerto Rico, and Ireland with local teams supporting client-specific automation platform implementations.

1 investor

Packaging Compliance Labs is an industry leader providing sterile packaging solutions, design validation, and contract packaging services for medical device and life sciences manufacturers. The company offers comprehensive testing and compliance expertise to help clients navigate product development and regulatory requirements.

1 investor

PackMaxQ designs and manufactures thermal packaging solutions for cold chain logistics in healthcare and life sciences. The company specializes in preserving temperature-sensitive products including blood, biologics, medications, and medical devices during transit.

1 investor

PaMeLa develops compact, low-burden medical devices that use artificial intelligence to objectively measure and visualize pain, addressing the reliance on patients' subjective self-reporting. The devices are designed for use in both hospitals and clinics, targeting healthcare providers and patients affected by acute and chronic pain.

1 investor

Pairidex offers FusionMRD, a personalized digital droplet PCR (ddPCR) assay that detects and quantifies oncogenic gene fusions from a standard peripheral blood sample to monitor treatment response and minimal residual disease in gene fusion-driven blood cancers such as leukemia. It is sold as a commercial service for oncologists and clinical researchers to support treatment decisions and shorten clinical trial timelines.

1 investor

Palisade Bio develops a PDE4 prodrug platform for treating immune, inflammatory, and fibrotic diseases, with improved pharmacokinetics and tolerability compared to traditional PDE4 inhibitors. The company's lead candidate is designed for once-daily dosing with reduced gastrointestinal side effects.

1 investor

Palliare develops medical devices for minimally invasive gastrointestinal procedures, including laparoscopy and endoscopy solutions. The company serves surgeons and endoscopists performing diagnostic and therapeutic interventions.

1 investor

Palm Therapeutics develops palmitoylation-targeted drugs using its proprietary PalmReader screening platform to identify novel therapeutic molecules. The company focuses on modulating protein palmitoylation, a post-translational modification involved in multiple disease pathways.

1 investor

Palodex Group operates the DEXIS digital ecosystem, an AI-powered platform combining 2D and 3D imaging, intraoral scanning, diagnostics, and treatment planning for dental practices. The company manufactures and integrates imaging devices and software solutions serving dental clinics and practitioners.

1 investor

Paloma Health provides NHS-contracted autism and ADHD assessments and support services, addressing long NHS wait times for families seeking diagnosis and care. The company operates clinics in Exeter and Norwich with a hybrid London-based support team.

1 investor